| human | Q5 |
| P2798 | Loop ID | 376120 |
| P856 | official website | https://pure.au.dk/portal/en/persons/peter-humaidan(6f40684a-2e80-418c-aa4b-bb23985f05ea).html |
| P496 | ORCID iD | 0000-0001-6884-5366 |
| P7293 | PLWABN ID | 9810544820105606 |
| P1153 | Scopus author ID | 57200607809 |
| P214 | VIAF ID | 73152682538023311327 |
| P108 | employer | Aarhus University | Q924265 |
| P735 | given name | Peter | Q2793400 |
| Peter | Q2793400 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| Q48565972 | 'Luteal coasting' after GnRH agonist trigger - individualized, HCG-based, progesterone-free luteal support in 'high responders': a case series |
| Q38041965 | (Meta)analyze this: Systematic reviews might lose credibility. |
| Q46129525 | 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study |
| Q64230707 | 45,X/46,XY Mosaicism and Normozoospermia in a Patient with Male Phenotype |
| Q34548143 | 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children |
| Q36959947 | A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology |
| Q48556571 | A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept |
| Q50656304 | A prospective study, using sibling oocytes, examining the effect of 30 seconds versus 90 minutes gamete co-incubation in IVF. |
| Q34875744 | A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology |
| Q50674897 | A strategy for treatment of couples with unexplained infertility who failed to conceive after intrauterine insemination. |
| Q40778859 | Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients. |
| Q91184065 | Advances in ovulation trigger strategies |
| Q36594336 | Agonist depot versus OCP programming of frozen embryo transfer: a retrospective analysis of freeze-all cycles. |
| Q82873462 | Agonist trigger: what is the best approach? Agonist trigger and low dose hCG |
| Q83042434 | Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review |
| Q35147441 | Aromatase inhibitors in stimulated IVF cycles. |
| Q49341753 | Artificial cryopreserved embryo transfer cycle success depends on blastocyst developmental rate and progesterone timing |
| Q51824972 | Association between maternal vascular murmur and the small-for-gestational-age fetus with abnormal umbilical artery Doppler flow. |
| Q35160859 | Azoospermia and ring chromosome 9--a case report. |
| Q70018943 | Behçet's disease (a severe case from Greenland) |
| Q48520837 | Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled study |
| Q37393945 | Biological versus chronological ovarian age: implications for assisted reproductive technology. |
| Q91296241 | Bureaucratic overheating is a parasite hampering modern clinical research - a viewpoint from the 'belly of the beast' |
| Q94668982 | COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management |
| Q88527804 | Case of successful IVF treatment of an oligospermic male with 46,XX/46,XY chimerism |
| Q49988311 | Clinical parameters of ovarian hyperstimulation syndrome (OHSS) following different hormonal triggers of oocyte maturation in IVF treatment. |
| Q89165748 | Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis |
| Q42697462 | Comparison of a 'freeze-all' strategy including GnRH agonist trigger versus a 'fresh transfer' strategy including hCG trigger in assisted reproductive technology (ART): a study protocol for a randomised controlled trial. |
| Q45815742 | Comparison of gene expression profiles in granulosa and cumulus cells after ovulation induction with either human chorionic gonadotropin or a gonadotropin-releasing hormone agonist trigger |
| Q41598862 | Concurrent oocyte retrieval and hysteroscopy: a novel approach in assisted reproduction freeze-all cycles. |
| Q39380673 | Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study |
| Q47607018 | Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial. |
| Q56971617 | Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders |
| Q48637726 | Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study |
| Q92850814 | Corrigendum to: Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive Outcome |
| Q88541068 | Corrigendum: Letter to the Editor: Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates |
| Q90680839 | Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of in vitro Fertilization/Intracytoplasmic Sperm Injection |
| Q48572942 | Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial. |
| Q52608598 | Daytime Variation in Serum Progesterone During the Mid-Luteal Phase in Women Undergoing In Vitro Fertilization Treatment. |
| Q91711377 | Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG |
| Q90320882 | Diagnostic Accuracy of a Point-of-Care Test for Celiac Disease Antibody Screening among Infertile Patients |
| Q48626458 | Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonis |
| Q48642375 | Dose of recombinant FSH and oestradiol concentration on day of HCG affect embryo development kinetics. |
| Q91842045 | Dual stimulation using corifollitropin alfa in 54 Bologna criteria poor ovarian responders - a case series |
| Q48622292 | Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles. |
| Q48529176 | Effect of GnRHa ovulation trigger dose on follicular fluid characteristics and granulosa cell gene expression profiles |
| Q100533181 | Effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota: protocol for a double-blind, placebo-controlled multicentre trial |
| Q35844053 | Efficacy and Safety of Pergoveris in Assisted Reproductive Technology--ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatment |
| Q38381555 | Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders |
| Q40186846 | Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders |
| Q37989262 | Elevated progesterone during ovarian stimulation for IVF. |
| Q89693824 | Embryotoxicity testing of IVF disposables: how do manufacturers test? |
| Q101121683 | Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment |
| Q35843213 | Endometrial Stromal Nodule: A Rarity and a Pathological Challenge |
| Q38495382 | Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles. |
| Q42314889 | Erratum to: 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children |
| Q91184058 | Female infertility and assisted reproductive technology |
| Q48158169 | Fertility after uterine artery embolization of fibroids: a systematic review |
| Q47388931 | Fertility preservation and refreezing of transplanted ovarian tissue-a potential new way of managing patients with low risk of malignant cell recurrence |
| Q55009345 | Follicle Size on Day of Trigger Most Likely to Yield a Mature Oocyte. |
| Q55116047 | Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center study. |
| Q48307208 | Frozen embryo transfer can be performed in the cycle immediately following the freeze-all cycle. |
| Q33770533 | GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis |
| Q46370791 | GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study |
| Q28308094 | GnRH agonist for triggering of final oocyte maturation: time for a change of practice? |
| Q48668054 | GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study. |
| Q38709165 | GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis. |
| Q38075689 | GnRH agonist triggering: recent developments. |
| Q40345765 | GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study |
| Q34636679 | GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study. |
| Q37553591 | GnRHa to trigger final oocyte maturation: a time to reconsider. |
| Q48623268 | GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients |
| Q48509401 | GnRHa trigger and luteal coasting: a new approach for the ovarian hyperstimulation syndrome high-risk patient? |
| Q38231926 | GnRHa trigger for final oocyte maturation: is HCG trigger history? |
| Q39142708 | Gonadotropin-releasing hormone agonist (GnRHa) trigger - State of the art. |
| Q48565420 | Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study. |
| Q50649587 | Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction. |
| Q91524801 | Hormonal stimulation of spermatogenesis: a new way to treat the infertile male with non-obstructive azoospermia? |
| Q35822351 | Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. |
| Q91184069 | Hot topics in female infertility: an afterword |
| Q93123826 | Hot topics in male infertility: an afterword |
| Q93378645 | How time to healthy singleton delivery could affect decision-making during infertility treatment: a Delphi consensus |
| Q48600778 | Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology--"the king is dead, long live the king!". |
| Q37425142 | Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study |
| Q33799681 | Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial |
| Q37372180 | Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment |
| Q91462825 | Increased body mass index associated with increased preterm delivery in frozen embryo transfers |
| Q59676371 | Increasing vaginal progesterone gel supplementation after frozen–thawed embryo transfer significantly increases the delivery rate |
| Q88215146 | Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates |
| Q52663984 | Individualized controlled ovarian stimulation in expected poor-responders: an update. |
| Q45585806 | LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango? |
| Q36134824 | LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles |
| Q92176102 | Large-for-gestational age is male-gender dependent in artificial frozen embryo transfers cycles: a cohort study of 1295 singleton live births |
| Q48680172 | Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin |
| Q90756652 | Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer |
| Q38355567 | Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches. |
| Q81641333 | Lutropin alfa: a viewpoint by Peter Humaidan |
| Q93123789 | Male infertility and assisted reproductive technology |
| Q79562088 | Malformation rate and sex ratio in 412 children conceived with epididymal or testicular sperm |
| Q59800369 | Mid-Luteal 17-OH Progesterone Levels in 614 Women Undergoing IVF-Treatment and Fresh Embryo Transfer—Daytime Variation and Impact on Live Birth Rates |
| Q50145850 | Mitochondrial DNA, a new biomarker of embryonic implantation potential: fact or fiction? |
| Q44785658 | Motivational interviewing: a part of the weight loss program for overweight and obese women prior to fertility treatment. |
| Q90433765 | Non-transparent and insufficient descriptions of non-validated microbiome methods and related reproductive outcome results should be interpreted with caution |
| Q55297649 | Nonspecific Symptoms in a Rare Case of Urethral Adenocarcinoma in a 58-Year-Old Female. |
| Q90597789 | Novel Physiology and Definition of Poor Ovarian Response; Clinical Recommendations |
| Q91396450 | Oocyte quantity, as well as oocyte quality, plays a significant role for the cumulative live birth rate of a POSEIDON criteria patient |
| Q38391766 | Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin. |
| Q38876689 | Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials |
| Q44085089 | Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation |
| Q90596028 | Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic review |
| Q39381311 | Pain relief during oocyte retrieval with a new short duration electro-acupuncture technique--an alternative to conventional analgesic methods |
| Q39348979 | Pain relief during oocyte retrieval--exploring the role of different frequencies of electro-acupuncture. |
| Q35296260 | Paraurethral leiomyoma in a postmenopausal woman: first European case |
| Q41546578 | Perinatal outcomes after fresh versus vitrified-warmed blastocyst transfer: retrospective analysis. |
| Q37427014 | Persistent Mullerian Duct Syndrome: a rare entity with a rare presentation in need of multidisciplinary management. |
| Q34009789 | Pharmaceutical options for triggering of final oocyte maturation in ART |
| Q84573370 | Polymorphisms in the protein C inhibitor gene in in vitro fertilization failure |
| Q88215036 | Poor definition of poor-ovarian response results in misleading clinical recommendations |
| Q88582358 | Predicting live birth for poor ovarian responders: the PROsPeR concept |
| Q36589271 | Pregnancy and birth after intracytoplasmic sperm injection with normal testicular spermatozoa in a patient with azoospermia and tail stump epididymal sperm |
| Q84642594 | Pregnancy loss after frozen-embryo transfer--a comparison of three protocols |
| Q50554078 | Prenatal diagnostics in TESA/PESA pregnancies in Denmark 1995-2007: a shift from invasive procedures to nuchal translucency examination. |
| Q46413354 | Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate |
| Q47596938 | Prevalence, incidence, and autoimmune comorbidities of celiac disease: a nation-wide, population-based study in Denmark from 1977 to 2016. |
| Q37736733 | Preventing ovarian hyperstimulation syndrome: guidance for the clinician. |
| Q58581631 | Progesterone levels on pregnancy test day after hormone replacement therapy-cryopreserved embryo transfer cycles and related reproductive outcomes |
| Q91503205 | Protein supplementation intake for bodybuilding and resistance training may impact sperm quality of subfertile men undergoing fertility treatment: a pilot study |
| Q42679678 | Psychological aspects of male fertility treatment. |
| Q45906758 | REPLY BY THE AUTHORS: Re: Persistent Mullerian Duct Syndrome: a rare entity with a rare presentation in need of multidisciplinary management. |
| Q48829972 | Recombinant human albumin as protein source in culture media used for IVF: a prospective randomized study. |
| Q56391239 | Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review |
| Q89766480 | Relationship between a uterine fibroid diagnosis and the risk of adverse obstetrical outcomes: a cohort study |
| Q57462944 | Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer |
| Q61852687 | Reproductive life in women with celiac disease; a nationwide, population-based matched cohort study |
| Q54268616 | Reproductive outcome of patients undergoing in vitro fertilisation treatment and diagnosed with bacterial vaginosis or abnormal vaginal microbiota: a systematic PRISMA review and meta-analysis. |
| Q46897592 | Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol |
| Q59676551 | Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study |
| Q92711682 | Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise |
| Q38854810 | Segmented ART - The new era in ART? |
| Q47417854 | Separation and characterization of maternal cardiac and vascular sounds in the third trimester of pregnancy. |
| Q87305772 | Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol |
| Q37949281 | Should Cochrane reviews be performed during the development of new concepts? |
| Q101240639 | Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations |
| Q80142904 | Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome |
| Q81560597 | Sperm chromatin structure assay parameters measured after density gradient centrifugation are not predictive for the outcome of ART |
| Q46743100 | Spermatozoa DNA damage measured by sperm chromatin structure assay (SCSA) and birth characteristics in children conceived by IVF and ICSI. |
| Q46161378 | Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. |
| Q48673105 | Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. |
| Q42693613 | Testing of sperm DNA damage and clinical recommendations |
| Q50494207 | Testosterone for Poor Ovarian Responders: Lessons From Ovarian Physiology. |
| Q89135758 | The 'Big Freeze': freeze-all should not be used for everyone |
| Q34458877 | The Luteal Phase after GnRHa Trigger-Understanding An Enigma |
| Q91868092 | The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists |
| Q34983821 | The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women |
| Q92844481 | The early luteal hormonal profile in IVF patients triggered with hCG |
| Q92887658 | The effect of intra-ovarian androgen priming on ovarian reserve parameters in Bologna poor responders |
| Q64123980 | The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles |
| Q55410116 | The impact of male overweight on semen quality and outcome of assisted reproduction. |
| Q37971192 | The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. |
| Q37635863 | The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome. |
| Q47673503 | The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI. |
| Q43571349 | The type of GnRH analogue used during controlled ovarian stimulation influences early embryo developmental kinetics: a time-lapse study. |
| Q38429206 | The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors |
| Q92018022 | Therapeutic endometrial scratching and implantation after in vitro fertilization: a multicenter randomized controlled trial |
| Q40338822 | To add or not to add LH: comments on a recent commentary. |
| Q33809638 | Treatment of Abnormal Vaginal Microbiota before Frozen Embryo Transfer: Case-Report and Minireview to Discuss the Longitudinal Treatment Efficacy of Oral Clindamycin |
| Q64899464 | Unrecognised coeliac disease among men and women undergoing fertility treatment: A screening study. |
| Q36723130 | Use of acupuncture in female infertility and a summary of recent acupuncture studies related to embryo transfer. |
| Q90824621 | Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive Outcome |
| Q91749280 | Vaginal microbiota and IVF outcomes: poor diagnosis results in flawed conclusions |
| Q79368834 | [Artificial fertilization and HIV-positive couples--a risk-reducing treatment] |
| Q95432412 | [From skepticism to acceptance of assisted reproduction] |
| Q70417204 | [Rheumatoid arthritis and spondyloarthritis ankylopoietica with aortic insufficiency in Greenlandic Eskimos] |
| Q81907208 | [Triplet pregnancy following IVF treatment with a single embryo] |
Search more.